- Home
- LGND vs AD Comparison
LGND vs AD Comparison
Compare LGND & AD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LGND | AD |
|---|---|---|
| Founded | 1987 | 1983 |
| Country | United States | United States |
| Employees | 68 | 4100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LGND | AD |
|---|---|---|
| Price | $195.24 | $45.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $245.86 | $55.00 |
| AVG Volume (30 Days) | ★ 183.6K | 148.4K |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 71.44% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.50 | $34.11 |
| Revenue Next Year | $18.28 | N/A |
| P/E Ratio | ★ $76.27 | $275.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $93.58 | $44.03 |
| 52 Week High | $227.92 | $77.13 |
Technical Indicators
Market Signals| Indicator | LGND | AD |
|---|---|---|
| Relative Strength Index (RSI) | 44.28 | 36.14 |
| Support Level | $179.55 | $44.62 |
| Resistance Level | $207.72 | $50.23 |
| Average True Range (ATR) | 10.02 | 1.17 |
| MACD | -1.59 | -0.13 |
| Stochastic Oscillator | 3.39 | 8.18 |
Price Performance
Historical ComparisonAbout LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About AD Array Digital Infrastructure Inc.
Array Digital Infrastructure, formerly US Cellular, sold its regional wireless operations serving about 4.4 million customers to T-Mobile in August 2025. The firm has agreed to sell most of its remaining spectrum licenses to Verizon and AT&T; however, it will still retain rights to C-band spectrum in several locations after these deals are closed. Array also owns a 5.5% stake in Verizon Wireless' Los Angeles operations and about 4,400 wireless towers.